SCHEMBL8767814

SCHEMBL8767814

CC(=O)c1ccc([C@H]2C[C@@]3(C)C(=CC[C@@]3(O)CCCO)[C@@H]3CC=C4CC(=O)CC[C@@H]4[C@@H]23)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8767828 0.86 — —
SCHEMBL8769020 0.80 — —
SCHEMBL8767954 0.75 CYP3A4 (0.33) —
SCHEMBL8768215 0.71 NR3C1 (0.35) —
SCHEMBL8767711 0.71 NR3C1 (0.35) —
SCHEMBL8767823 0.71 PGR (0.40) —
SCHEMBL8768030 0.66 NR3C1 (0.41) —
SCHEMBL8767831 0.66 PGR (0.53) —
SCHEMBL8652053 0.65 PGR (0.45) —
SCHEMBL8653263 0.65 PGR (0.45) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567469-B1 14beta-H-, 14- AND 15-EN-11beta-ARYL-4-ESTRENES SCHERING AG (DE) 1997-08-27 — — EP claimed
EP-0567469-B1 14beta-H-, 14- AND 15-EN-11beta-ARYL-4-ESTRENES SCHERING AG (DE) 1997-08-27 — — EP disclosed
US-5426102-A Antigestagenic, antiandrogenic, antiglucocorticoid, antimineralcorticoid properties SCHERING AKTIENGESELLSCHAFT (DE) 1995-06-20 — — US disclosed
Send feedback